Stockreport

Evaxion to announce business update and full year 2025 financial results on March 5, 2026

Evaxion Biotech A/S - American Depositary Share  (EVAX) 
PDF COPENHAGEN, Denmark, March 2, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology [Read more]